The Dangers of Undermining Patient Choice: Lessons from Europe and Canada on September 19th

Published September 7, 2006

The Dangers of Undermining Patient Choice: Lessons from Europe and Canada

While there is a growing international consensus that patients should be empowered to be more actively involved in their health care decisions, government policies often limit their options. And these limitations can block patients’ access to innovative, high-quality health care. Nonetheless, members of Congress are proposing initiatives in the U.S. that would limit patient choice and undermine their access to innovative care. How do we know that would happen? Because the European and Canadian health care systems have already incorporated many of those restrictions and know from experience what impact they have. Proposals that would centralize control of the new Medicare drug benefit, for example, would move us down the European path toward restrictions and limited options for seniors.

Please join the Institute for Policy Innovation and the Galen Institute on September 19 as we host a Capitol Hill policy briefing featuring international experts who will provide insights into their countries’ health care systems, including their governments’ role in regulating physicians and hospitals and imposing price controls and restrictions on access to medicines. Learn what this could mean for access to modern, innovative quality health care in the U.S.


Fredrik Erixon, Chief Economist, Timbro

Valentin Petkantchin, Associate Researcher, Institut Economique Molinari

Alberto Mingardi, Director, Instituto Bruno Leoni

Brian Lee Crowley, President, Atlantic Institute for Market Studies

Moderated by:
Merrill Matthews, Resident Scholar, Institute for Policy Innovation &
Julian Morris, Executive Director, International Policy Network

Tuesday, September 19, 2006
10:00 AM – Noon, 210 Cannon House Office Building, Capitol Hill

RSVP: Sonia Blumstein, [email protected], 202.213.0379

Available LIVE via Webcast at